| Social contacts and mixing patterns relevant to the spread of infectious diseases J Mossong, N Hens, M Jit, P Beutels, K Auranen, R Mikolajczyk, ... PLoS Med 5 (3), e74, 2008 | 2988 | 2008 |
| Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021 | 2677* | 2021 |
| The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study K Prem, Y Liu, TW Russell, AJ Kucharski, RM Eggo, N Davies, S Flasche, ... The Lancet Public Health 5 (5), e261-e270, 2020 | 2416 | 2020 |
| Age-dependent effects in the transmission and control of COVID-19 epidemics NG Davies, P Klepac, Y Liu, K Prem, M Jit, RM Eggo Nature Medicine 26, 1205–1211, 2020 | 1888 | 2020 |
| Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment OJ Wouters, KC Shadlen, M Salcher-Konrad, AJ Pollard, HJ Larson, ... The Lancet 397 (10278), 1023-1034, 2021 | 1185 | 2021 |
| Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ... The Lancet Global Health 8 (8), e1003-e1017, 2020 | 1077 | 2020 |
| Projecting social contact matrices in 152 countries using contact surveys and demographic data. K Prem, AR Cook, M Jit PLoS computational biology 13 (9), e1005697, 2017 | 867 | 2017 |
| Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ... The Lancet 395 (10224), 575-590, 2020 | 528 | 2020 |
| Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis T Malagón, M Drolet, MC Boily, EL Franco, M Jit, J Brisson, M Brisson The Lancet infectious diseases 12 (10), 781-789, 2012 | 528 | 2012 |
| Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection K Abbas, SR Procter, K van Zandvoort, A Clark, S Funk, T Mengistu, ... The Lancet Global Health 8 (10), e1264-e1272, 2020 | 363 | 2020 |
| Economic evaluation of human papillomavirus vaccination in the United Kingdom M Jit, YH Choi, WJ Edmunds Bmj 337, 2008 | 338 | 2008 |
| The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories Y Liu, C Morgenstern, J Kelly, R Lowe, M Jit BMC medicine 19 (1), 1-12, 2021 | 317 | 2021 |
| COVID-19 vaccine challenges: What have we learned so far and what remains to be done? R Forman, S Shah, P Jeurissen, M Jit, E Mossialos Health Policy 125 (5), 553-567, 2021 | 290 | 2021 |
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic … M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ... The Lancet Public Health 1 (1), e8-e17, 2016 | 279 | 2016 |
| Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study M Jit, M Brisson, A Portnoy, R Hutubessy The Lancet Global Health 2 (7), e406-e414, 2014 | 277 | 2014 |
| The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy D Cromer, AJ van Hoek, M Jit, WJ Edmunds, D Fleming, E Miller Journal of Infection 68 (4), 363-371, 2014 | 256 | 2014 |
| Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study TW Russell, JT Wu, S Clifford, WJ Edmunds, AJ Kucharski, M Jit The Lancet Public Health 6 (1), e12-e20, 2020 | 218 | 2020 |
| Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White, WJ Edmunds Vaccine 28 (12), 2370-2384, 2010 | 208 | 2010 |
| Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models MA Penny, R Verity, CA Bever, C Sauboin, K Galactionova, S Flasche, ... The Lancet 387 (10016), 367-375, 2016 | 204 | 2016 |
| The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ... PLoS medicine 13 (11), e1002181, 2016 | 192 | 2016 |
John EdmundsProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
